Hutchison MediPharma Named Pilot Company to Participate in “Inspection and Quarantine Reform Program” for Importing Bio-samples to Zhangjiang Hi-Tech Park

The award ceremony of “The Inspection and Quarantine Reform Program” for importing bio-samples to Zhangjiang Hi-Tech Park took place at Shanghai Zhangjiang (Group) Co. Ltd. on the afternoon of March 9, with appearances from the leaders and officials of SIQSAQ, the Shanghai Entry Exit Inspection and Quarantine Bureau. Hutchison MediPharma was labeled as the Pilot Company to participate in “the Inspection and Quarantine Reform Program” for importing bio-samples to Zhangjiang Hi-Tech Park.

Recommended by Shanghai Zhangjiang (Group) Co. Ltd. and assessed by Shanghai Entry Exit Inspection and Quarantine Bureau, Hutchison MediPharma is honored to receive this title.